Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative based on genetically engineered immune cells could help prevent arteries from becoming blocked with plaque Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative based on genetically engineered immune cells could help prevent arteries from becoming blocked with plaque New Scientist – News
CAR T-cell therapy could help prevent clogged arteries
